CHD vs CLX
Church & Dwight and Clorox, side by side.
Prices and company dataas of yesterday's close
- CHDBuy more2.2%
Church & Dwight's report on Oct 30 beat profit forecasts by 2.2%, and the stock rose 14% over the past month.
- CLXSell some60%
Clorox's report on Nov 2 beat profit forecasts by 60%, but the stock rose 7.8% over the past five trading days while other food, drink and household stocks barely moved.
Percent return
- CHD+32.70%
- CLX+6.91%
Nov 11, 2025 to Nov 11, 2026
Where they differ
- Company size: CHD $22.7B, CLX $12.0B.
- Sales growth, 1 yr: CHD +1.7%, CLX +6.3%. CLX is ahead.
- Price for $1 of next year's profit: CHD $27, CLX $17. CLX is ahead.
- Profit per $1 of sales: CHD 19¢, CLX 14¢. CHD is ahead.
- Cash minus debt: CHD −$1.93B, CLX −$5.41B. CHD is ahead.
- Price change, 1 yr: CHD +33%, CLX +6.9%. CHD is ahead. S&P 500 +12%.
- How much the price swings: CHD 22%, CLX 34%. CHD is ahead.
| Measure | CHDChurch & Dwight | CLXClorox |
|---|---|---|
| Price and returns | ||
| Price | $111.96 | $106.92 |
| Today | +0.18% | Best in this row: +0.30% |
| 1 month | +14.18% | Best in this row: +29.37% |
| 3 months | Best in this row: +9.26% | +1.38% |
| This year | Best in this row: +34.86% | +11.37% |
| 1 year | Best in this row: +32.70% | +6.91% |
| 5 years | Best in this row: +31.70% | −22.68% |
| From 52-week high | −0.1% | −12.6% |
| How much it swings (90 days) | Best in this row: 22% | 34% |
| Valuation | ||
| Market value | $22.7B | $12.0B |
| Price vs last year's earnings | 31.5× | Best in this row: 16.2× |
| Price vs next year's expected earnings | 27.4× | Best in this row: 17.4× |
| Price vs earnings, adjusted for growth | 3.50× | – |
| Price to sales | 4.1× | Best in this row: 1.7× |
| Price vs cash it brings in | Best in this row: 24.4× | 26.7× |
| Company value vs operating profit | 19.9× | Best in this row: 13.5× |
| Growth | ||
| Revenue growth, 1 year | +1.7% | Best in this row: +6.3% |
| Revenue growth a year, last 3 years | Best in this row: +4.9% | −3.1% |
| Earnings per share growth, last year | Best in this row: +29.4% | +10.3% |
| Earnings per share growth expected next year | Best in this row: +7.5% | +7.5% |
| Profitability | ||
| Kept from sales after making the product | Best in this row: 45.7% | 41.9% |
| Kept as operating profit | Best in this row: 18.6% | 14.3% |
| Kept as final profit | Best in this row: 12.4% | 9.4% |
| Kept as spare cash | Best in this row: 16.9% | 6.3% |
| Profit on shareholders' money | 17.8% | Best in this row: 534.4% |
| Profit on all money put in | 14.1% | Best in this row: 14.2% |
| Balance sheet | ||
| Net cash (cash minus debt) | Best in this row: −$1.93B | −$5.41B |
| Debt for each $1 of shareholders' money | Best in this row: 0.53× | 46.23× |
| Short-term assets per $1 of bills due | Best in this row: 0.96× | 0.65× |
| Dividend yield | 1.13% | Best in this row: 5.00% |
| Share of profit paid as dividends | Best in this row: 38% | 90% |
| Our readPro | ||
| Our call | Buy more | Sell some |
| Why | Church & Dwight's report on Oct 30 beat profit forecasts by 2.2%, and the stock rose 14% over the past month. | Clorox's report on Nov 2 beat profit forecasts by 60%, but the stock rose 7.8% over the past five trading days while other food, drink and household stocks barely moved. |
| Where the price sits | in the full report | in the full report |
| Our overall score (out of 100) | Best in this row: 54 | 46 |
| Our value score | 33 | Best in this row: 72 |
| Our growth score | Best in this row: 48 | 32 |
| Our quality score | Best in this row: 77 | 60 |
| Our price trend score | Best in this row: 61 | 33 |
| Earnings and analysts | ||
| Analyst consensus | Buy | Hold |
| To average analyst target | Best in this row: +0.4% | −15.1% |
| Average analyst target | $112.45 | $90.83 |
| Analysts rating it a buy | Best in this row: 48% | 6% |
| Buy ratings added, 3 months | 0 | 0 |
| Analysts covering | 12 | 13 |
CHD: our only Buy more, with more analyst upside
Our pick of these: Church & Dwight
+0.4% to the average analyst target, vs −15.1%
CHD +0.4%, CLX −15.1%.Keeps 18.6% of sales as operating profit, vs 14.3%
CHD 18.6%, CLX 14.3%.48% of analysts rate it a buy, vs 6%
CHD 48%, CLX 6%.Where it loses: CLX has faster sales growth, +6.3% vs +1.7%
Cover this stock to see the full report
The call, its reasons and what would change it are free for everyone. The price zones, the whole brief and how the call has moved come with covering a stock. Use one of your three covered slots, or go Pro for every stock.
Prices as of yesterday, 3:59 PM ET. A view, not advice.